Dr. Pieter Cullis
Fellow
Current Employer
The University of British Columbia
Election Year
2004
Academy
Academy of Science
Discipline
Medical Sciences
Department
Department of Biochemistry and Molecular Biology
Keywords
Cancer chemotherapy, drug delivery, biomembranes, liposomes, gene therapy
LONG
Pieter Cullis is a scientist whose research has been focused on understanding the roles of lipids in biological membranes and the development of model membrane systems (liposomes) with applications in cancer chemotherapy. His work has led to the development of two liposomal formulations of drugs that have been approved by regulatory agencies for the treatment of the fungal infections often associated with cancer chemotherapy and for the treatment of metastatic breast cancer. In addition, two other liposomal drugs based on his work are in clinical development for the treatment of non-Hodgkin's lymphoma and metastatic melanoma.
SHORT
Pieter Cullis’ research is on the role of lipids in biological membranes and the development of model membrane systems (liposomes) with applications in cancer chemotherapy. His work has led to the development of two drugs for the treatment of the fungal infections often associated with cancer chemotherapy and for the treatment of metastatic breast cancer.
Pieter Cullis is a scientist whose research has been focused on understanding the roles of lipids in biological membranes and the development of model membrane systems (liposomes) with applications in cancer chemotherapy. His work has led to the development of two liposomal formulations of drugs that have been approved by regulatory agencies for the treatment of the fungal infections often associated with cancer chemotherapy and for the treatment of metastatic breast cancer. In addition, two other liposomal drugs based on his work are in clinical development for the treatment of non-Hodgkin's lymphoma and metastatic melanoma.
SHORT
Pieter Cullis’ research is on the role of lipids in biological membranes and the development of model membrane systems (liposomes) with applications in cancer chemotherapy. His work has led to the development of two drugs for the treatment of the fungal infections often associated with cancer chemotherapy and for the treatment of metastatic breast cancer.